Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Initial phase III results reported for KeraVision Ring

Sep. 17, 1997

AMO Array Multifocal IOL approved for marketing in U.S.

Sep. 11, 1997

Tolmetin eyedrop formulation evaluated in rabbits

Sep. 9, 1997

Improved IOP-lowering prostaglandin analogues from Alcon

Sep. 4, 1997

Alcon reports new agents for controlling IOP

Aug. 26, 1997

CAT's anti-TGF-beta2 antibody approved for phase I/IIa trials

Aug. 26, 1997

FDA approves expansion of Sunrise Technologies' hyperopia study

Aug. 26, 1997

InSite Vision initiates phase II study of ISV-120

Aug. 21, 1997

Generic levobunolol approved in Canada

Aug. 13, 1997

FDA releases Staar's implantable contact lens for phase II trials

Aug. 11, 1997

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...